Center-Authored Papers

Filters: Author is Morgan, Cecilia A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zak DE, Andersen-Nissen E, Peterson ER, Sato A, Hamilton KM, Borgerding J, Krishnamurty AT, Chang JT, Adams DJ, Hensley TR et al..  2012.  Merck Ad5/HIV induces broad innate immune activation that predicts CD8+ T-cell responses but is attenuated by preexisting Ad5 immunity.. Proceedings of the National Academy of Sciences of the United States of America. 109(50):E3503-12. Abstract
K
Kublin JG, Morgan CA, Day TA, Gilbert PB, Self SG, McElrath MJ, Corey L.  2012.  HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.. Clinical investigation. 2(3):245-254. Abstract
D
Deschamps MM, Metch B, Morgan CA, Zorilla CD, Donastorg Y, Swann E, Taina D, Patrice J, Pape WJ.  2016.  Feasibility of Identifying a Female Sex Worker Cohort at High Risk of HIV Infection in the Caribbean for HIV Vaccine Efficacy Trials: Longitudinal Results of HVTN 907.. Journal of acquired immune deficiency syndromes (1999). 71(1):70-7. Abstract
Day TA, Morgan CA, Kublin JG.  2013.  Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity? Clinical Investigation. 3(5):413-415.
C
Cheng C, Gall JGD, Nason M, King RC, Koup RA, Roederer M, McElrath MJ, Morgan CA, Churchyard G, Baden LR et al..  2010.  Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization.. Journal of virology. 84(1):630-8. Abstract